A Case of Management for Hepatocellular Carcinoma with Lung Metastasis
Journal of Liver Cancer
;
: 129-133, 2016.
Article
in Korean
| WPRIM
| ID: wpr-76009
ABSTRACT
Liver cancer is the 2nd most common cause of cancer related death in Korea. Especially, patients who present extrahepatic spread of hepatocellular carcinoma (HCC) have a shorter life expectancy (50% survival at 1 year and less than 4 months of median overall survival). Molecular target agent like sorafenib was usually mentioned as a treatment for them, but that was still not firmly established. We present a 75 year-old who had expanding nodular type of HCC. The mass was removed by resection and radiofrequency ablation. However, lung metastasis were revealed shortly after surgery. That lesions were treated with lenvatinib and systemic chemotherapy.
Full text:
Available
Index:
WPRIM (Western Pacific)
Main subject:
Life Expectancy
/
Catheter Ablation
/
Carcinoma, Hepatocellular
/
Drug Therapy
/
Molecular Targeted Therapy
/
Korea
/
Liver Neoplasms
/
Lung
/
Neoplasm Metastasis
Limits:
Humans
Country/Region as subject:
Asia
Language:
Korean
Journal:
Journal of Liver Cancer
Year:
2016
Type:
Article
Similar
MEDLINE
...
LILACS
LIS